Get Connected:

Irritable Bowel Syndrome
The MD Magazine Irritable Bowel Syndrome condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Growth Rate of Gut Bacteria Related to Specific Diseases
Changes in gut bacterial growth rates may be linked to onset of diseases, such as type 2 diabetes or irritable bowel syndrome, for example, according to research published in the journal Science.
Treatments for irritable bowel system are proliferating. In addition to new drugs, more drug candidates are entering the approval pipeline. Even as physicians await these new products, their patients are getting into the act by doing internet research and other reading—and tv watching—that has them trying unproven remedies with mixed results.
Some microbes are more associated with specific irritable bowel disease symptoms than others, researchers reporting at the American College of Gastroenterology Scientic Meeting reported.
IBS patients are great, because many times they come to you frustrated they don't have a "diagnosis".
Whether patients have irritable bowel syndrome or inflammatory bowel disease what matters to them most is getting the correct diagnosis and treatment as quickly as possible.
The US Food and Drug Association (FDA) granted approval for eluxadoline (Viberzi) and rifaximin (Xifaxan), to treat irritable bowel syndrome with diarrhea (IBS-D) in adult men and women.
Some intestinal bacteria cause more pain than others in patients with irritable bowel syndrome, according to study results reported by a team of researchers from North Carolina.

Most Popular

$vacMongoViewPlus$ $vAR$